Filed before 2025Filed 15 October 2019
Arcellx, Inc. has sold $42.8M so far
Arcellx, Inc., a biotech company based in Gaithersburg, MD, has sold $42.8M so far in its equity round, according to a filing dated 15 October 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 15 October 2019
- First filed
- 22 August 2019
- Round
- Equity round (amended filing)
- Amount sold
- $42.8M
- Offering size
- $83.7M
- Investors so far
- 18
- Based in
- Gaithersburg, MD
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 90% of the 1,781 tracked raises with an amount filed in 2019, and than 84% of the 146 in biotech.
Arcellx, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Feb 2023 | New filing | $100M | Another raise |
| 10 Mar 2022 | New filing | $10M | Another raise |
| 1 Jul 2021 | Amended filing | $120M | Another raise |
| 9 Apr 2021 | New filing | $115M | Another raise |
| 15 Oct 2019 | Amended filing | $42.8M | This raise |
| 22 Aug 2019 | New filing | $41.8M | This raise |
More with NEA on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.